Welcome to the Podiatry Arena forums, for communication between foot health professionals about podiatry and related topics.
You are currently viewing our podiatry forum as a guest which gives you limited access to view all podiatry discussions and access our other features. By joining our free global community of Podiatrists and other interested foot health care professionals you will have access to post podiatry topics (answer and ask questions), communicate privately with other members (PM), upload content, view attachments, receive a weekly email update of new discussions, earn CPD points and access many other special features. Registered users do not get displayed the advertisments in posted messages. Registration is fast, simple and absolutely free so please, join our global Podiatry community today!
If you have any problems with the registration process or your account login, please contact contact us.
[ FRIDAY, JULY 15, 2005 03:32:41 PM]
CHENNAI: Hyderabad-based Bharat Biotech, a manufacturer of vaccines and biotherapeutics, on Friday launched 'Regen-D' therapeutic in the market for treatment of diabetic foot ulcers, burns and skin grafts.
Addressing a press conference, Bharat Biotech chairman and managing director Krishna M Ella claimed that the new product, developed after nearly five years and Rs 18 crore worth of research, had nearly 90 per cent healing rate.
He said in India alone, nearly 40,000 limbs were amputated due to diabetes and throughout the world, upto 70 per cent of all leg amputations happened to people with uncontrolled diabetes. Nearly 1.20 lakh deaths occurred due to burns every year in the country.
Ella said this was the first time in the country or in the world that a product to treat diabetic foot ulcers had been developed, which could be used even for burns and skin grafts. He expected a Rs 500 crore market for this new product in the country in the years to come.
The company, which had already launched four vaccines in the market in the last few years including for hepatitis-B and typhoid, has a state-of-the-art facility in Genome Valley in Hyderabad put up on an investment of Rs 120 crore.
Using an Ozone Machine to generate 03 applied gaseous to infected extremity while in contrast bath for 30 minutes 2X/day for 7 days will heal a large portion of these lesions. The device is traditionally connected to a hot tub as a way to non-chemically kell bacteria and virus. When applied in the manner described above, many lesions unresponsive to chemo-therapeutic agents can be healed. Pablo, San Diego
"Cure" for diabetic foot ulcer launched
Linear Mode
